CVS Health Corporation CVS
Transcripts78
Date range2006-02-06 – 2025-05-01
Calls charted78
Sentiment timeline
Net Loughran-McDonald sentiment per call (×1000), earliest → latest.
CEO vs CFO
Average sentiment of each executive's remarks per call. Divergence is a signal.
Prepared remarks vs Q&A
Scripted tone vs unscripted answers. The gap is information.
Prepared remarksQ&A responses
Tone vs forward expectations
Management tone next to Wall Street's forward-looking numbers (glopardo): the 12-month forward EPS estimate and the forward P/E per call.
Forward EPS estimate
Forward P/E
Divergence watch ⚑
Quarters where tone and the forward EPS estimate moved opposite ways.
- 2014 Q4
tone ↓ -3.0
fwd EPS ↑ +0.22
Tone cooled even as the forward EPS estimate rose.
- 2016 Q3
tone ↓ -6.4
fwd EPS ↑ +0.20
Tone cooled even as the forward EPS estimate rose.
- 2020 Q1
tone ↓ -12.8
fwd EPS ↑ +0.13
Tone cooled even as the forward EPS estimate rose.
- 2021 Q1
tone ↓ -2.6
fwd EPS ↑ +0.11
Tone cooled even as the forward EPS estimate rose.
- 2021 Q4
tone ↓ -2.2
fwd EPS ↑ +0.14
Tone cooled even as the forward EPS estimate rose.
- 2022 Q1
tone ↓ -2.8
fwd EPS ↑ +0.20
Tone cooled even as the forward EPS estimate rose.
- 2022 Q3
tone ↓ -4.5
fwd EPS ↑ +0.27
Tone cooled even as the forward EPS estimate rose.
- 2024 Q2
tone ↑ +10.4
fwd EPS ↓ -1.09
Tone rose while the forward EPS estimate was cut.
- 2024 Q3
tone ↑ +2.6
fwd EPS ↓ -0.32
Tone rose while the forward EPS estimate was cut.
Recent transcripts
| Call | Date | Sentiment ×1000 | Fwd EPS | Fwd P/E | |
|---|
| 2025 Q1 | 2025-05-01 | +15.9 | — | — | View → |
| 2024 Q4 | 2025-02-12 | +18.5 | — | — | View → |
| 2024 Q3 | 2024-11-06 | +14.1 | $7.12 | 8.2 | View → |
| 2024 Q2 | 2024-08-07 | +11.5 | $7.45 | 8.2 | View → |
| 2024 Q1 | 2024-05-01 | +1.1 | $8.54 | 8.8 | View → |
| 2023 Q4 | 2024-02-07 | +12.9 | $8.52 | 8.8 | View → |
| 2023 Q3 | 2023-11-01 | +11.9 | $8.60 | 8.2 | View → |
| 2023 Q2 | 2023-08-02 | +10.4 | $8.73 | 7.6 | View → |